Zhejiang Tianyuan News
Most Popular Zhejiang Tianyuan Story
Novartis wants China as its No. 3 market
Novartis has upped the ante in China. Today, the Swiss drugmaker said it was buying an 85 percent chunk of the Chinese vaccines maker Zhejiang Tianyuan for $125 million. And that's just one-tenth of Read more...
Latest Headlines
- November 4, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
